Clinical Foundations 16
Humidification During Invasive and Noninvasive Ventilation
By Ruben Restrepo, MD, RRT, FAARC
and Brian Walsh, RRT-NPS, ACCS, FAARC
Panel Discussion: Humidification During Invasive and Noninvasive Ventilation
Moderator: Ruben Restrepo, MD, RRT, FAARC
Clinical Foundations 15
Waste Anesthetic Gases (WAGs) among Employees
in the Healthcare Industry
James D. McGlothlin, MPH, PhD, CPE and John E. Moenning, DDS, MSD
Panel Discussion: Waste Anesthetic Gases:
Opinions from the Experts
Panelists: David Farr, MD, Joni Brady, MSN, RN, CAPA, Jim McGlothlin, MD
Clinical Foundations 14
Aerosol Therapy for Ventilator-Dependent Patients:
Devices, Issues, Selection & Technique
Arzu Ari, PhD, RRT, PT, CPFT, FAARC
Panel Discussion: Aerosol Therapy In Spontaneously Breathing & Mechanically Ventilated Patients: Description, Selection & Issues
Moderator: Tim Myers, RRT-NPS, MBA, FAARC
Clinical Foundations 13
Postoperative Pulmonary Complications
By David A Grooms MSHS, RRT
Clinical Foundations 12
Filtration of breathing gases
By Joe Hylton, BSRT, RRT-NPS, FAARC
Panel Discussion: Filtration of breathing gases during mechanical ventilation
Moderator: Ruben Restrepo, MD, RRT, FAARC
|
|
New Module Clinical Foundations 17
CDC Recommendations on Preventing VAP
Sara Hanif Mirza, MD, MS
Carl A. Kaplan, MD
Mechanical ventilation is required in up to 50% of all critically ill patients during their hospital course. Ventilator-associated pneumonia (VAP) is not uncommon and is known to be associated with increased morbidity, mortality and length of stay. Currently, there is a renewed focus on VAP due to the financial reimbursement with a pay for performance fee structure. The pathogenesis of VAP is hypothesized to be due to the introduction of bacteria into the sterile lower respiratory tract. This article addresses the CDC recommendations for the known modifiable risk factors for VAP, back rest elevation, maintaining endotracheal tube cuff pressure, selection of endotracheal tube and placement, ventilator circuit care, de-contamination of oral flora, and minimizing sedation in the mechanically ventilated patient.
Panel Discussion: Preventing Ventilator-Associated Pneumonia (VAP)
Moderator: Marin Kollef, MD
Panelists: Teresa Volsko, MHHS, RRT, FAARC, Robert Joyner, PhD, RRT,Mark Konkle, MPA, RRT
In this panel discussion, 4 experts convene to discuss topics related to ventilator-associated pneumonia (VAP). Topics include (1) the importance of preventing disruptions in the ventilator circuit in order to prevent ventilator-associated infections such as VAP, iatrogenic viral infections including influenza, and aspiration events; (2) the need for VAP prevention protocols in all ICU’s caring for mechanically ventilated patients; (3) the role of cost-effectiveness of novel technologies, including specialized endotracheal tubes for ICU prevention programs; (4) means to minimize exposure to mechanical ventilation as a preventive measure against complications such as VAP; (5) whether VAP should be regarded as a quality indicator of ICU care, and (6) how to employ The Centers for Disease Control and Prevention new criteria for evaluating the quality of care provided in the intensive care setting, ventilator-associated conditions (VACs) and infection-related ventilator-associated conditions (IVACs).
|
|